ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,650.00
-25.00 (-0.93%)
At close: Apr 28, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 52.15 billion as of April 28, 2026. Its market cap has increased by 205.86% in one year.
Market Cap
52.15B
Enterprise Value
57.54B
Revenue
12.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,650.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 52.15B, an increase of 105.76%. That is a compound annual growth rate of 12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 52.15B | 57.03% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 78.37B |
| Psomagen | 73.10B |
| Ark Solutions | 68.91B |
| HLB Pep | 68.12B |
| Aptamer Sciences | 64.81B |
| EyeGene | 62.55B |
| J2KBIO | 50.11B |
| NGeneBio | 45.23B |